Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion

類似資料

• Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
  著者:: Xuemei Liang, 等
  出版事項: (2022-09-01)
• Efficacy of Intravitreal Dexamethasone Implant in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion and Resistant to Intravitreal Ranibizumab Injection
  著者:: Ayşe Ergin, 等
  出版事項: (2022-12-01)
• Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
  著者:: S. K. Mishra, 等
  出版事項: (2018-03-01)
• A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
  著者:: Alper Halil Bayat, 等
  出版事項: (2019-12-01)
• Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
  著者:: Frederic Matonti, 等
  出版事項: (2012-10-01)